NCT02843685View on ClinicalTrials.gov

Regression Discontinuity Design to Evaluate of Drotrecogin Alpha Effectiveness

CompletedOBSERVATIONAL
Enrollment

12,492

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

December 31, 2005

Conditions
Sepsis
Interventions
DRUG

Drotrecogin alfa activated

Trial Locations (1)

02118

Boston Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Boston Medical Center

OTHER